Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.2%
Thu, 17 Oct 9:54

BLISS GVS PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.2%Image source: Nikada/www.istockphoto.com

BLISS GVS PHARMA share price has zoomed 6% and is presently trading at Rs 135.7.

Meanwhile, the BSE HEALTHCARE index is at 44,560.2 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 2.2%) and GSK Pharma (up 2.1%).

Torrent Pharma (down 1.7%) and Jubilant Pharmova (down 1.3%) are among the top losers today.

Over the last one year, BLISS GVS PHARMA has moved up from Rs 89.3 to Rs 135.7, registering a gain of Rs 46.4 (up 52.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,560.2, registering a gain of 58.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 198.8%), Glenmark Pharma (up 122.4%) and SUVEN PHARMACEUTICALS (up 114.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,199.3 (down 0.4%).

The top losers among the BSE Sensex today are M&M (down 2.6%) and Maruti Suzuki (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,821.7 (down 0.6%). Bajaj Auto and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,199.3, registering a gain of 15,032.4 points (up 22.7%).

BLISS GVS PHARMA Financial Update...

BLISS GVS PHARMA net profit grew 53.8% YoY to Rs 221 million for the quarter ended June 2024, compared to a profit of Rs 144 million a year ago. Net sales rose 15.1% to Rs 1,836 million during the period as against Rs 1,595 million in April-June 2023.

For the year ended March 2024, BLISS GVS PHARMA reported 6.3% increase in net profit to Rs 816 million compared to net profit of Rs 767 million during FY23. Revenue of the company grew 2.5% to Rs 7,702 million during FY24.

The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 16.0.


Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.2%". Click here!